We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Backs GDUFA II Proposals, Advancing Reauthorization of Fee Program
Industry Backs GDUFA II Proposals, Advancing Reauthorization of Fee Program
Industry groups have backed the FDA’s commitment goals for GDUFA II, bringing the user fee program closer to reauthorization after Friday’s public meeting.